Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden
- 31 December 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 180 (6), 2423-2430
- https://doi.org/10.1016/j.juro.2008.08.044
Abstract
To what extent active surveillance and deferred treatment for localized risk prostate cancer are used is unclear. We assessed the use of surveillance and of deferred treatment in a population based, nationwide cohort in Sweden. In the National Prostate Cancer Register of Sweden, with a 98% coverage vs the compulsory Swedish Cancer Registry, we identified 8,304 incident cases of prostate cancer in 1997 to 2002 with age younger than 70 years, clinical local stage T1 or 2, N0 or Nx, M0 or Mx and serum prostate specific antigen less than 20 ng/ml. Data were extracted from medical charts for 7,782 of these men (94%) at a median of 4 years after diagnosis. Primary treatment was surveillance for 2,065 men (26%), radical prostatectomy for 3,722 (48%), radiotherapy for 1,632 (21%) and hormonal treatment for 363 (5%). Men on surveillance had lower local tumor stage, grade and prostate specific antigen, and were older than those who received active primary treatment (p <0.001). After a median surveillance of 4 years 711 men (34%) on surveillance had received deferred treatment, which was radical prostatectomy for 279 (39%), radiotherapy for 212 (30%) and hormonal treatment for 220 (30%). Surveillance was a common treatment for patients younger than 70 years with localized prostate cancer in Sweden in 1997 to 2002, 26% of men with localized prostate cancer started surveillance and after a median followup of 4 years, 66% of these men remained on surveillance.Keywords
This publication has 17 references indexed in Scilit:
- Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins ExperienceJournal of Urology, 2007
- Short- and Long-term Mortality With Localized Prostate CancerArchives of Internal Medicine, 2007
- Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Scandinavian Journal of Urology and Nephrology, 2007
- Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly MenPublished by American Medical Association (AMA) ,2006
- Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United StatesJNCI Journal of the National Cancer Institute, 2006
- Active Surveillance for Prostate Cancer: For Whom?Journal of Clinical Oncology, 2005
- Active Surveillance with Selective Delayed Intervention Using PSA Doubling Time for Good Risk Prostate CancerEuropean Urology, 2005
- Active surveillance: towards a new paradigm in the management of early prostate cancerThe Lancet Oncology, 2004
- Time Trends and Characteristics of Men Choosing Watchful Waiting for Initial Treatment of Localized Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- Early detection and aggressive treatment of prostate cancerJournal of General Internal Medicine, 2000